ES2161692T3 - Derivados de tiazolidindiona, produccion y uso de los mismos. - Google Patents

Derivados de tiazolidindiona, produccion y uso de los mismos.

Info

Publication number
ES2161692T3
ES2161692T3 ES92910028T ES92910028T ES2161692T3 ES 2161692 T3 ES2161692 T3 ES 2161692T3 ES 92910028 T ES92910028 T ES 92910028T ES 92910028 T ES92910028 T ES 92910028T ES 2161692 T3 ES2161692 T3 ES 2161692T3
Authority
ES
Spain
Prior art keywords
same
tiazolidindiona
derivatives
production
derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92910028T
Other languages
English (en)
Spanish (es)
Inventor
Takashi Sohda
Hitoshi Ikeda
John C Greenfield
Jerry R Colca
Edgar N Petzold
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Pharmacia and Upjohn Co
Original Assignee
Takeda Chemical Industries Ltd
Pharmacia and Upjohn Co
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=13672917&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2161692(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Takeda Chemical Industries Ltd, Pharmacia and Upjohn Co, Upjohn Co filed Critical Takeda Chemical Industries Ltd
Application granted granted Critical
Publication of ES2161692T3 publication Critical patent/ES2161692T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Lubricants (AREA)
  • Graft Or Block Polymers (AREA)
ES92910028T 1991-04-11 1992-04-06 Derivados de tiazolidindiona, produccion y uso de los mismos. Expired - Lifetime ES2161692T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP7883691 1991-04-11

Publications (1)

Publication Number Publication Date
ES2161692T3 true ES2161692T3 (es) 2001-12-16

Family

ID=13672917

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92910028T Expired - Lifetime ES2161692T3 (es) 1991-04-11 1992-04-06 Derivados de tiazolidindiona, produccion y uso de los mismos.

Country Status (19)

Country Link
EP (1) EP0579733B1 (enExample)
JP (1) JP3176694B2 (enExample)
KR (1) KR100249988B1 (enExample)
AT (1) ATE202352T1 (enExample)
AU (1) AU1743292A (enExample)
CA (1) CA2106967C (enExample)
CZ (1) CZ196693A3 (enExample)
DE (1) DE69231886T2 (enExample)
DK (1) DK0579733T3 (enExample)
ES (1) ES2161692T3 (enExample)
FI (1) FI934426L (enExample)
GR (1) GR3036623T3 (enExample)
HU (1) HUT68370A (enExample)
MX (1) MX9201637A (enExample)
NO (1) NO933615D0 (enExample)
PT (1) PT100366A (enExample)
SK (1) SK109993A3 (enExample)
TW (1) TW209864B (enExample)
WO (1) WO1992018501A1 (enExample)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993022445A1 (en) * 1992-05-05 1993-11-11 The Upjohn Company A process for producing pioglitazone metabolite
TW268952B (enExample) * 1993-02-26 1996-01-21 Takeda Pharm Industry Co Ltd
CZ289317B6 (cs) * 1994-04-11 2002-01-16 Sankyo Company Limited Heterocyklická sloučenina, farmaceutický prostředek ji obsahující a její pouľití
TW438587B (en) * 1995-06-20 2001-06-07 Takeda Chemical Industries Ltd A pharmaceutical composition for prophylaxis and treatment of diabetes
US5952509A (en) * 1996-06-27 1999-09-14 Takeda Chemical Industries, Ltd. Production of benzaldehyde compounds
DE69837089T2 (de) 1997-06-18 2007-06-21 Smithkline Beecham P.L.C., Brentford Behandlung der diabetes mit thiazolidindion und sulfonylharnstoff
CZ20011629A3 (cs) 1998-11-12 2001-12-12 Smithkline Beecham Plc Farmaceutický prostředek pro upravené uvolňování senzitizéru inzulínu a jiných antidiabetických přípravků
AR023700A1 (es) 1998-11-12 2002-09-04 Smithkline Beecham Plc Un procedimiento para preparar una composicion farmaceutica que comprende un sensibilizador de insulina
GB0014969D0 (en) 2000-06-19 2000-08-09 Smithkline Beecham Plc Novel method of treatment
DE20119200U1 (de) 2001-11-27 2003-04-10 Joh. Winklhofer & Söhne GmbH und Co KG, 81369 München Kettenspanner mit mechanischer Verriegelung
US8268352B2 (en) 2002-08-05 2012-09-18 Torrent Pharmaceuticals Limited Modified release composition for highly soluble drugs
US8216609B2 (en) 2002-08-05 2012-07-10 Torrent Pharmaceuticals Limited Modified release composition of highly soluble drugs
KR100646128B1 (ko) 2005-04-21 2006-11-14 전라옥 ＰＰＡＲγ에 선택적으로 작용하는 테트라하이드로퀴놀린계열 티아졸리딘디온 유도체 및 그 합성방법
AU2013200104B2 (en) * 2006-03-16 2014-05-15 Metabolic Solutions Development Company, Llc Thiazolidinedione analogues for the treatment of metabolic inflammation mediated disease
MX2008011870A (es) * 2006-03-16 2009-02-10 Metabolic Solutions Dev Compan Terapias de combinacion de analogos de tiazolidindiona y agonistas glucocorticoides.
CA2646207C (en) * 2006-03-16 2016-01-19 Metabolic Solutions Development Company Thiazolidinedione analogues for the treatment of metabolic inflammation mediated disease
ES2388555T3 (es) * 2006-03-16 2012-10-16 Metabolic Solutions Development Company Llc Análogos de tiazolidindiona
US7435741B2 (en) 2006-05-09 2008-10-14 Teva Pharmaceutical Industries, Ltd. 2-N{5-[[4-[2-(methyl-2-pyridinylamino) ethoxy] phenyl]methyl]-2,4-thiazolidinedione} butanedioic acid, methods of preparation and compositions with rosiglitazone maleate
WO2008038359A1 (en) * 2006-09-28 2008-04-03 Daido Kogyo Co., Ltd. Chain tensioner
US8304441B2 (en) 2007-09-14 2012-11-06 Metabolic Solutions Development Company, Llc Thiazolidinedione analogues for the treatment of metabolic diseases
NZ597381A (en) 2007-09-14 2013-03-28 Metabolic Solutions Dev Co Llc Thiazolidinedione analogues for the treatment of diabetes and inflammatory diseases
US8722710B2 (en) 2007-09-26 2014-05-13 Deuterx, Llc Deuterium-enriched pioglitazone
HUE038042T2 (hu) * 2009-12-15 2018-09-28 Cirius Therapeutics Inc PPAR helyettesítõ tiazolidindion sók metabolikus betegségek kezelésére
EP2560956B1 (en) * 2010-04-19 2016-10-26 Octeta Therapeutics, LLC Novel synthesis for thiazolidinedione compounds
AU2011242955A1 (en) * 2010-04-19 2012-11-01 Metabolic Solutions Development Company, Llc Novel synthesis for thiazolidinedione compounds
HUE031424T2 (en) 2010-08-10 2017-07-28 Octeta Therapeutics Llc New synthesis of thiazolidinedione compounds
PL2603507T3 (pl) * 2010-08-10 2016-12-30 Synteza związków tiazolidynodionu
US20120094959A1 (en) 2010-10-19 2012-04-19 Bonnie Blazer-Yost Treatment of cystic diseases
JP6800013B2 (ja) * 2013-03-14 2020-12-16 ポクセル・ソシエテ・アノニムＰｏｘｅｌ ＳＡ 重水素化２，４−チアゾリジンジオン及び治療方法
US10188639B2 (en) 2014-01-15 2019-01-29 Deuterx, Llc Methods of treating neurological, metabolic, and other disorders using enantiopure deuterium-enriched pioglitazone
SG11201608218QA (en) * 2014-04-02 2016-10-28 Minoryx Therapeutics S L 2,4-thiazolidinedione derivatives in the treatment of central nervous system disorders
WO2016071727A1 (en) 2014-11-04 2016-05-12 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for the prevention and the treatment of rapidly progressive glomerulonephritis
AU2017370003B2 (en) 2016-12-01 2023-04-13 Minoryx Therapeutics S.L. 5-[[4-[2-[5-(1-hydroxyethyl)pyridin-2-yl]ethoxy]phenyl]methyl]-1,3-thiazolidine- 2,4-dione for treating nonalcoholic fatty liver disease
ES2926580T3 (es) * 2016-12-23 2022-10-27 Minoryx Therapeutics S L Proceso para preparar 5-[[4-[2-[5-(1-hidroxietil)-2-piridinil]etoxi]fenil]metil]-2,4-tiazolidindiona y sales de la misma
US11767317B1 (en) 2020-06-30 2023-09-26 Poxel Sa Methods of synthesizing enantiopure deuterium-enriched pioglitazone
US11319313B2 (en) 2020-06-30 2022-05-03 Poxel Sa Crystalline forms of deuterium-enriched pioglitazone
WO2024231881A2 (en) * 2023-05-09 2024-11-14 Minoryx Therapeutics S.L. Polymorphic forms and formulations of leriglitazone

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5522636A (en) * 1978-08-04 1980-02-18 Takeda Chem Ind Ltd Thiazoliding derivative
AR240698A1 (es) * 1985-01-19 1990-09-28 Takeda Chemical Industries Ltd Procedimiento para preparar compuestos de 5-(4-(2-(5-etil-2-piridil)-etoxi)benzil)-2,4-tiazolidindiona y sus sales

Also Published As

Publication number Publication date
GR3036623T3 (en) 2001-12-31
DE69231886T2 (de) 2002-03-28
FI934426A7 (fi) 1993-10-08
CA2106967A1 (en) 1992-10-12
EP0579733B1 (en) 2001-06-20
EP0579733A1 (en) 1994-01-26
TW209864B (enExample) 1993-07-21
AU1743292A (en) 1992-11-17
CA2106967C (en) 2003-12-09
KR100249988B1 (ko) 2000-04-01
SK109993A3 (en) 1994-12-07
JPH0586057A (ja) 1993-04-06
DK0579733T3 (da) 2001-10-15
FI934426A0 (fi) 1993-10-08
MX9201637A (es) 1993-08-01
PT100366A (pt) 1993-06-30
NO933615L (no) 1993-10-08
HUT68370A (en) 1995-06-28
WO1992018501A1 (en) 1992-10-29
JP3176694B2 (ja) 2001-06-18
FI934426L (fi) 1993-10-08
CZ196693A3 (en) 1994-05-18
DE69231886D1 (de) 2001-07-26
ATE202352T1 (de) 2001-07-15
NO933615D0 (no) 1993-10-08

Similar Documents

Publication Publication Date Title
FI934426A0 (fi) Tiazolidindionderivat, framstaellning och anvaendning daerav
DE69325454D1 (de) Taxol-derivate
MY107158A (en) 3-arylcarbonyl; -1h-indoles useful as therapeutic agents.
MX9300662A (es) Derivados fosfonooxi y carbonato de taxol
ES2133410T3 (es) Derivados sustituidos de la tiazolidindiona.
ES2114931T3 (es) Nuevos esteres esteroidales.
FI914175A0 (fi) Tillsatsaemnen foer att foerbaettra adhesionen i bildaecks kord och fastheten i vulkaniserade gummi- blandningar.
SE8904298D0 (sv) New compounds
UY24010A1 (es) Nuevos pirrolocarbazoles
FI920526L (fi) Ringsubstituerade 2-amino-1,2,3,4- tetrahydronaftalener och 3-aminokromaner.
FI961507A0 (fi) Antrasyklinonijohdannaiset ja niiden käyttö amyloidoosissa
ES2118945T3 (es) Derivados de melamina utilizados en el tratamiento del cancer.
ES2059625T3 (es) Un procedimiento para preparar un derivado de hidroxialquilcisteina.
PA8465101A1 (es) Compuestos de triazina
MX9601635A (es) Derivados de antraciclina.
YU48915B (sh) Sulfonilkarbamid i postupak za njegovo dobijanje
ES2111768T3 (es) Derivados de carboestirilo utilizados como agentes antiarritmicos.
ES2136799T3 (es) Benzotiofenos de glucopiranosido.
FI923841A7 (fi) Substituerade mandelsyraderivat, foerfarande foer deras framstaellning och deras anvaendning som laekemedel
ITBO910132A1 (it) Apparecchiatura per l'alimentazione di articoli a forma di barretta, per esempio sigarette, ad una macchina utilizzatrice.
IT1320107B1 (it) Procedimento per la preparazione di derivati tassanici.
AR012730A1 (es) Compuestos derivados de aminocicloalquilpirrolidina sustituida cis-sustituidos, droga, agente antimicrobiano y compuesto intermediario
TR199701298T1 (xx) Tetralinler.
MX9200874A (es) Compuestos de una composicion especifica, un procedimiento para su produccion y su uso.
ES2109962T3 (es) Derivados de la naftiridina condensados.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 579733

Country of ref document: ES